Skip to main content
. 2014 Sep 30;21(2):114–118. doi: 10.5761/atcs.oa.14-00187

Table 1.

Characteristics of the patients

Case Age Gender Primary disease HJ PS Treatment site Initial treatment Postoperative treatment Survival time (days) Outcome Cause of after death


before after before after
1 70 male lung cancer 4 1 4 1 bifurcation to TIM none radiotherapy 59 dead cachexia
2 57 male lung cancer 3 2 2 1 bifurcation to TIM none chemotherapy 227 alive -
3 50 female breast cancer 5 2 3 2 bifurcation to TIM chemotherapy radiotherapy 40 dead RF
4 44 male lung cancer 5 2 3 1 bifurcation to TIM surgery, chemothrary none 146 dead RF
5 78 female lung cancer 5 5 4 4 bifurcation to TIM SBRT none 13 dead RF
6 56 male lung cancer 3 2 2 1 bifurcation to TIM chemoradiotherapy none 29 dead RF
7 45 female lung cancer 4 1 3 1 bifurcation to TIM chemotherapy none 14 dead cachexia
8 74 female thyroid cancer 4 2 3 2 bifurcation to TIM surgery none 25 dead RF
9 54 female breast cancer 4 2 2 1 bifurcation to TIM surgery, chemothrapy radiotherapy 207 dead RF
10 67 female tracheal cancer 5 2 4 1 bifurcation to TIM chemoradiotherapy none 745 dead RF
11 55 female lung cancer 2 3 1 3 bifurcation to TIM chemotherapy none 15 dead RF
12 61 male lung cancer 4 4 4 4 bifurcation to LMB chemoradiotherapy none 51 dead RF

HJ: Hugh-Jones classification; PS: performance status; RF: respiratory failure; SBRT: stereotactic body radiotherapy; TIM: truncus intermedius; LMB: left main bronchus